Lars Jørgen Østergaard

Corrigendum to "Immunogenicity, reactogenicity and persistence of meningococcal A, C,W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years" [Vaccine 27 (2009) 161-168] (DOI:10.1016/j.vaccine.2008.08.075)

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debateResearchpeer-review

  • Lars Østergaard
  • Edouard Lebacq, Clinique Notre-Dame de Grâce
  • ,
  • Jan Poolman, GlaxoSmithKline
  • ,
  • Gudrun Maechler, GlaxoSmithKline
  • ,
  • Dominique Boutriau, GlaxoSmithKline
Original languageEnglish
JournalVaccine
Volume27
Issue52
Pages (from-to)7467
Number of pages1
ISSN0264-410X
DOIs
Publication statusPublished - 9 Dec 2009

See relations at Aarhus University Citationformats

ID: 207061513